Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Colorectal cancer cells expressing Mex3a drive recurrence after chemotherapy

Many patients with colorectal cancer (CRC) relapse after chemotherapy. Tumor cells that do not completely adapt to their environment (owing to an incomplete set of CRC driver mutations) enter a latent state, in which the expression of Mex3a is upregulated. Mex3a+ cells are chemoresistant and reactivate after treatment, which leads to regeneration of the disease.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Lineage-tracing analysis of Mex3a+ cells in CRC mouse organoids during chemotherapy.


  1. Lo, Y.-H., Karlsson, K. & Kuo, C. J. Applications of organoids for cancer biology and precision medicine. Nat. Cancer 1, 761–773 (2020). A Review article that discusses the potential of organoids for personalized medicine.

    Article  Google Scholar 

  2. Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017). This Review discusses the role of tumor environment niche factors in cancer stem cell plasticity.

    Article  CAS  Google Scholar 

  3. Nusse, Y. M. et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559, 109–113 (2018). This Article reveals the acquisition of a fetal-like program by the damaged intestinal mucosa.

    Article  CAS  Google Scholar 

  4. Boumahdi, S. & de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat. Rev. Drug Discov. 19, 39–56 (2020). A Review article discussing the importance of cellular plasticity and the microenvironment in therapy resistance.

    Article  CAS  Google Scholar 

  5. Shen, S., Vagner, S. & Robert, C. Persistent Cancer. Cells: The Deadly Survivors. Cell 183, 860–874 (2020). This Article reviews the mechanisms utilized by tumor cells to survive drug treatments.

    Article  CAS  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Batlle, E. et al. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy. Nat. Cancer (2022).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Colorectal cancer cells expressing Mex3a drive recurrence after chemotherapy. Nat Cancer 3, 1024–1025 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer